Investigating how prenatal exposure to e-cigarettes affects blood platelets.
The Effects of Prenatal Thirdhand E-cigarette Exposure on Platelets
This study is looking at how being around e-cigarette smoke during pregnancy might affect blood platelets and the risk of blood clot-related diseases for both moms and their babies, so we can better understand the potential dangers of e-cigarette use while pregnant.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10704132 on NIH RePORTER |
What this research studies
This research explores the effects of prenatal exposure to thirdhand e-cigarette smoke on blood platelets and their role in thrombotic diseases. It aims to understand how this exposure impacts normal blood clotting and the development of diseases related to blood clots. The study will utilize a novel exposure model to assess the health effects of e-cigarettes on pregnant individuals and their offspring, focusing on various e-cigarette devices and liquids. By examining these factors, the research seeks to provide insights into the potential risks associated with e-cigarette use during pregnancy.
Who could benefit from this research
Good fit: Ideal candidates for this research include pregnant individuals who use e-cigarettes or are exposed to thirdhand smoke.
Not a fit: Patients who have not been exposed to e-cigarettes or thirdhand smoke during pregnancy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and prevention of thrombotic diseases in individuals exposed to e-cigarettes in utero.
How similar studies have performed: While there is existing research on the effects of smoking and e-cigarettes, this specific investigation into prenatal thirdhand e-cigarette exposure is novel and has not been extensively studied.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Khasawneh, Fadi T — Texas A&m University Health Science Ctr
- Study coordinator: Khasawneh, Fadi T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.